Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Medical Initiatives Syringe Program – Civil Settlement

In November 2017, AmerisourceBergen reached an “agreement in principle” with the United States Attorney’s Office for the Eastern District of New York to resolve civil claims under the False Claims Act involving the distribution of oncology support drugs from a facility not registered with the U.S. Food and Drug Administration. AmerisourceBergen agreed to pay $625 million to settle the matter. In August 2017, AmerisourceBergen pleaded guilty to a misdemeanor offense and paid $260 million in connection with the failure of AmerisourceBergen subsidiary Medical Initiatives to duly register with the FDA (see AmerisourceBergen instance, “Medical Initiatives Syringe Program – Criminal Settlement”). The settlement was finalized in October 2018.

Misconduct Type
Health
Enforcement Agency
Justice
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Settlement Announcement
11/21/2017
Contractors Involved Penalty
Total
AmerisourceBergen $625,000,000
Further Information Released
DOJ Press Release 10/1/2018
Form 8-K 11/21/2017

See also:

Federal Contractor Misconduct Database